Zobrazeno 1 - 9
of 9
pro vyhledávání: '"Angela Y, Moore"'
Autor:
Angela Y. Moore, MD, Kara Hurley, BSA
Publikováno v:
JAAD Case Reports, Vol 31, Iss , Pp 16-18 (2023)
Externí odkaz:
https://doaj.org/article/4abeb99553a44c56a0a78c2d54ca5964
Autor:
Ayman Grada, James Q. Del Rosso, Angela Y. Moore, Linda Stein Gold, Julie Harper, Giovanni Damiani, Katharina Shaw, Sabine Obagi, Raidah J. Salem, S. Ken Tanaka, Christopher G. Bunick
Publikováno v:
Frontiers in Medicine, Vol 9 (2022)
BackgroundVestibular side effects such as dizziness and vertigo can be a limitation for some antibiotics commonly used to treat acne, rosacea, and other dermatology indications.ObjectiveUnlike minocycline, which is a second-generation tetracycline, s
Externí odkaz:
https://doaj.org/article/16e46e7c57ce48f7a80440146fe4efab
Autor:
Stefano G. Daniele, Sa Rang Kim, Ayman Grada, Angela Y. Moore, Kathleen C. Suozzi, Christopher G. Bunick
Publikováno v:
American Journal of Clinical Dermatology. 24:199-223
Autor:
Matthew J. Zirwas, Zoe D. Draelos, Janet DuBois, Leon H. Kircik, Angela Y. Moore, Linda Stein Gold, Javier Alonso-Llamazares, Michael Bukhalo, Suzanne Bruce, Kimmie Eads, Lawrence J. Green, Scott T. Guenthner, Laura K. Ferris, Seth B. Forman, Steven E. Kempers, Edward Lain, Charles W. Lynde, David M. Pariser, Darryl P. Toth, Paul S. Yamauchi, Robert C. Higham, David Krupa, Patrick Burnett, David R. Berk
Publikováno v:
JAMA Dermatology.
ImportanceCurrent topical treatment options for seborrheic dermatitis are limited by efficacy and/or safety.ObjectiveTo assess safety and efficacy of roflumilast foam, 0.3%, in adult patients with seborrheic dermatitis affecting the scalp, face, and/
Autor:
Nathalie C, Zeitouni, Neal, Bhatia, Roger I, Ceilley, Joel L, Cohen, James Q, Del Rosso, Angela Y, Moore, Gilly, Munavalli, David M, Pariser, Todd, Schlesinger, Daniel M, Siegel, Andrea, Willey, Mitchel P, Goldman
Publikováno v:
J Clin Aesthet Dermatol
Photodynamic therapy (PDT) can be an effective treatment for actinic keratosis (AK) as well as selected non-melanoma skin cancers (NMSCs), such as Bowen's disease and superficial basal cell carcinoma. PDT has also demonstrated effectiveness in the ma
Autor:
Ayman Grada, James Q. Del Rosso, Emmy Graber, Christopher G. Bunick, Linda Stein Gold, Angela Y. Moore, Hilary Baldwin, Zaidal Obagi, Giovanni Damiani, Timothy Carrothers, Brian McNamee, Eva Hanze
Publikováno v:
Dermatologic Therapy. 35
Tetracycline-class antibiotics are frequently prescribed by dermatologists, commonly for acne vulgaris. Gastrointestinal absorption of first and second-generation tetracycline-class antibiotics, including doxycycline and minocycline, may be reduced b
Autor:
Angela Y Moore, Blakely S Richardson
Publikováno v:
Clinical, Cosmetic and Investigational Dermatology, Vol 2010, Iss default, Pp 49-58 (2010)
Angela Y Moore, Blakely S RichardsonArlington Center for Dermatology, Arlington, Texas, USAAbstract: Psoriasis is a chronic T-cell-mediated inflammatory disease that primarily affects the skin and joints. Patients with moderate to severe psoriasis co
Externí odkaz:
https://doaj.org/article/c1d1b21a87444fe895d8ee5a90d17a9d
Autor:
Mark G, Lebwohl, Leon H, Kircik, Angela Y, Moore, Linda, Stein Gold, Zoe D, Draelos, Melinda J, Gooderham, Kim A, Papp, Jerry, Bagel, Neal, Bhatia, James Q, Del Rosso, Laura K, Ferris, Lawrence J, Green, Adelaide A, Hebert, Terry, Jones, Steven E, Kempers, David M, Pariser, Paul S, Yamauchi, Matthew, Zirwas, Lorne, Albrecht, Alim R, Devani, Mark, Lomaga, Amy, Feng, Scott, Snyder, Patrick, Burnett, Robert C, Higham, David R, Berk
Publikováno v:
JAMA. 328:1073
ImportanceOnce-daily roflumilast cream, 0.3%, a potent phosphodiesterase 4 inhibitor, demonstrated efficacy and was well tolerated in a phase 2b trial of patients with psoriasis.ObjectiveTo evaluate the efficacy of roflumilast cream, 0.3%, applied on
Autor:
Kim A. Papp, David N. Adam, Melinda J. Gooderham, Lawrence J. Green, Mark Lebwohl, Angela Y. Moore, David M. Pariser, Amy Feng, Robert C. Higham, Patrick Burnett, David R. Berk
Publikováno v:
Journal of the American Academy of Dermatology. 87:AB180